Group One Trading
PDLI

Group One Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Group One Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,500
Closed -$24.2K – 6153
2019
Q4 		$24K Buy
+7,500
New +$21.8K ﹤0.01% 4311
2019
Q1 		– Sell
-254
Closed -$857 – 5808
2018
Q4 		$1K Buy
+254
New +$698 ﹤0.01% 4786
2018
Q2 		– Sell
-1,662
Closed -$4.64K – 5846
2018
Q1 		$5K Sell
1,662
-500
-23% -$1.36K ﹤0.01% 4534
2017
Q4 		$6K Sell
2,162
-6,149
-74% -$18.9K ﹤0.01% 4549
2017
Q3 		$28K Buy
8,311
+4,300
+107% +$12K ﹤0.01% 3923
2017
Q2 		$10K Sell
4,011
-8,900
-69% -$20.5K ﹤0.01% 4235
2017
Q1 		$29K Sell
12,911
-7,048
-35% -$15.6K ﹤0.01% 3719
2016
Q4 		$42K Buy
+19,959
New +$55.7K ﹤0.01% 3361
2016
Q3 		– Sell
-13,127
Closed -$41.7K – 5353
2016
Q2 		$41K Sell
13,127
-10,300
-44% -$34.3K ﹤0.01% 3432
2016
Q1 		$78K Buy
23,427
+16,400
+233% +$51.1K ﹤0.01% 2997
2015
Q4 		$25K Buy
7,027
+1,000
+17% +$4.19K ﹤0.01% 3812
2015
Q3 		$30K Sell
6,027
-10,100
-63% -$57.9K ﹤0.01% 3847
2015
Q2 		$104K Sell
16,127
-2,889
-15% -$19.4K ﹤0.01% 3061
2015
Q1 		$134K Buy
19,016
+15,449
+433% +$112K ﹤0.01% 2690
2014
Q4 		$28K Sell
3,567
-7,404
-67% -$58.6K ﹤0.01% 3780
2014
Q3 		$82K Buy
+10,971
New +$102K ﹤0.01% 3174
2013
Q4 		– Sell
-3,023
Closed -$25.5K – 6004
2013
Q3 		$24K Sell
3,023
-9,022
-75% -$72.5K ﹤0.01% 4082
2013
Q2 		$93K Buy
+12,045
New +$93.9K ﹤0.01% 2889

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading's PDLI Position: Q1 2020 in Review

Group One Trading sold out of PDL BioPharma, Inc. (PDLI) in Q1 2020, closing a stake of 7,500 shares — an estimated $24.2K sold.

Group One Trading first reported a position in PDLI in Q2 2013 and held it in 18 quarters. The position peaked at $134K in Q1 2015. 132 funds tracked by Wall St. Rank hold PDLI as of Q1 2020.

  • Group One Trading reported no remaining PDL BioPharma, Inc. position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 7,500 PDL BioPharma, Inc. shares in Q1 2020, an estimated $24.2K.
  • Group One Trading first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 18 quarters.
  • Group One Trading's PDL BioPharma, Inc. position peaked at $134K in Q1 2015.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.